CLASS II ONGOING Device recall · Reported 29 Jul 2026 · FDA Enforcement Report

TheraSphere 360 Y-90 Management Platform recalled by Boston Scientific

Boston Scientific is recalling TheraSphere 360 Y-90 Management Platform, distributed nationwide in the US. The recall was initiated on 19 Jun 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 00191506068264, All released software versions (V1.1.2, V1.2.1, V1.2.2. V2.0.1, V2.0.2)
Quantity recalled68 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2771-2026
FDA event ID
99236
Recalling firm
Boston Scientific, Maple Grove, MN
Classification
Class II
Status
Ongoing
Recall initiated
19 Jun 2026
FDA classified
22 Jul 2026
Reported
29 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Device Malfunction

Timeline

19 Jun 2026Recall initiated by company
22 Jul 2026Classified by FDA+33 days
29 Jul 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Software anomaly occurs when a user adds one or more vials to the cart and subsequently returns to the Activity Calculator to modify one or more input. When a user modifies an input and selects "Recalculate", the dose calculation is updated correctly; however, any vials that were previously added to the cart are not automatically updated to reflect the revised calculation.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Boston Scientific TheraSphere 360 Y-90 Management Platform, Model Number M00139509001; Radiological Image Processing System.

Where it was distributed

US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, FL, GA, IL, IN, LA, MA, MN, NE, NY, OH, OK, OR, SC, SD, TN, TX, UT, WA, WI, WV, WY.

Nationwide AlabamaArkansasArizonaCaliforniaColoradoFloridaGeorgiaIllinoisIndianaLouisianaMassachusettsMinnesotaNebraskaNew YorkOhioOklahomaOregonSouth CarolinaSouth DakotaTennessee

Questions about this recall

Why was it recalled?

Software anomaly occurs when a user adds one or more vials to the cart and subsequently returns to the Activity Calculator to modify one or more input. When a user modifies an input and selects "Recalculate", the dose calculation is updated correctly; however, any vials that were previously added to the cart are not automatically updated to reflect the revised calculation.

Which lots are affected?

UDI/DI 00191506068264, All released software versions (V1.1.2, V1.2.1, V1.2.2. V2.0.1, V2.0.2)

Where was it sold?

US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, FL, GA, IL, IN, LA, MA, MN, NE, NY, OH, OK, OR, SC, SD, TN, TX, UT, WA, WI, WV, WY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Boston Scientific

All 628

Other Other Medical Devices recalls

All 13,908